Drug intelligence / Profile preview

ebracteolata Hayata extract

Development stage
Unknown
Lead developer
Shuguang Hospital
Administration
Transdermal, Topical
01

Overview

Ebracteolata Hayata extract is a botanical preparation derived from the roots of *Euphorbia ebracteolata* Hayata, a plant species utilized in Traditional Chinese Medicine (TCM) under the name Langdu. This specific extract is being investigated as the active pharmaceutical ingredient in a novel transdermal delivery system—a liposome nanofiber patch—designed for the treatment of actinic keratosis (AK). The extract contains a variety of bioactive secondary metabolites, including diterpenoids (such as jolkinolides) and acetophenones, which are reported to possess anti-proliferative, pro-apoptotic, and anti-inflammatory properties. In the context of actinic keratosis, the extract is intended to induce cell death in dysplastic keratinocytes. The liposome nanofiber formulation is employed to enhance the solubility, stability, and skin penetration of the hydrophobic components within the extract, potentially improving therapeutic efficacy while minimizing systemic exposure.

Other names
Euphorbia ebracteolata Hayata extractLangdu extractextract of Euphorbia ebracteolata Hayata
02

Targets

P-gp (Multidrug resistance protein 1 (ABCB1))Sucrase-Isomaltase

Beyond the preview

Go deeper on ebracteolata Hayata extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ebracteolata Hayata extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call